Whittier Trust CO Catalent, Inc. Transaction History

Whittier Trust CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 25, 2023	SELL	$41.39 - $81.0 $331 - $648	-8 Reduced 13.79%	50 $0
Q3 2022 Oct 21, 2022	SELL	$72.36 - $113.1 $2,677 - $4,184	-37 Reduced 38.95%	58 $4,000
Q2 2022 Jul 28, 2022	SELL	$87.2 - $114.05 $1,482 - $1,938	-17 Reduced 15.18%	95 $10,000
Q1 2022 Apr 29, 2022	BUY	$94.19 - $124.49 $3,767 - $4,979	40 Added 55.56%	112 $12,000
Q3 2021 Nov 01, 2021	BUY	$109.17 - $142.35 $2,401 - $3,131	22 Added 44.0%	72 $10,000
Q2 2021 Jul 29, 2021	BUY	$100.34 - $115.69 $5,017 - $5,784	50 New	50 $5,000

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Whittier Trust CO, based on Form 13F filings with the SEC.

Stay updated on Whittier Trust CO with notifications on news.